These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 23643286)

  • 1. Inflammation and microvascular dysfunction in cardiac syndrome X patients without conventional risk factors for coronary artery disease.
    Recio-Mayoral A; Rimoldi OE; Camici PG; Kaski JC
    JACC Cardiovasc Imaging; 2013 Jun; 6(6):660-7. PubMed ID: 23643286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relation between cardiovascular risk factors and coronary microvascular dysfunction in cardiac syndrome X.
    Sestito A; Lanza GA; Di Monaco A; Lamendola P; Careri G; Tarzia P; Pinnacchio G; Battipaglia I; Crea F
    J Cardiovasc Med (Hagerstown); 2011 May; 12(5):322-7. PubMed ID: 21135582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac adrenergic nerve function and microvascular dysfunction in patients with cardiac syndrome X.
    Di Monaco A; Bruno I; Sestito A; Lamendola P; Barone L; Bagnato A; Nerla R; Pisanello C; Giordano A; Lanza GA; Crea F
    Heart; 2009 Apr; 95(7):550-4. PubMed ID: 19164330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation between stress-induced myocardial perfusion defects on cardiovascular magnetic resonance and coronary microvascular dysfunction in patients with cardiac syndrome X.
    Lanza GA; Buffon A; Sestito A; Natale L; Sgueglia GA; Galiuto L; Infusino F; Mariani L; Centola A; Crea F
    J Am Coll Cardiol; 2008 Jan; 51(4):466-72. PubMed ID: 18222358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelial dysfunction as assessed by flow-mediated dilation in patients with cardiac syndrome X: role of inflammation.
    Tondi P; Santoliquido A; Di Giorgio A; Sestito A; Sgueglia GA; Flore R; Careri G; Pinnacchio G; Lanza GA; Crea F
    Eur Rev Med Pharmacol Sci; 2011 Sep; 15(9):1074-7. PubMed ID: 22013731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obesity, inflammation and brachial artery flow-mediated dilatation: therapeutic targets in patients with microvascular angina (cardiac syndrome X).
    Ong P; Sivanathan R; Borgulya G; Bizrah M; Iqbal Y; Andoh J; Gaze D; Kaski JC
    Cardiovasc Drugs Ther; 2012 Jun; 26(3):239-44. PubMed ID: 22392186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of thiol levels, thiol/disulfide homeostasis and their relation with inflammation in cardiac syndrome X.
    Altiparmak IH; Erkus ME; Sezen H; Demirbag R; Kaya Z; Sezen Y; Gunebakmaz O; Asoglu R; Besli F; Neselioglu S; Erel O
    Coron Artery Dis; 2016 Jun; 27(4):295-301. PubMed ID: 26928883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated circulating soluble form of CD40 ligand in patients with cardiac syndrome X.
    Dominguez-Rodriguez A; Abreu-Gonzalez P; Avanzas P; Gomez MA; Kaski JC
    Atherosclerosis; 2010 Dec; 213(2):637-41. PubMed ID: 20980002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective study of C-reactive protein as a state marker in Cardiac Syndrome X.
    Dollard J; Kearney P; Clarke G; Moloney G; Cryan JF; Dinan TG
    Brain Behav Immun; 2015 Jan; 43():27-32. PubMed ID: 25064176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The serum pentraxin-3 is elevated in patients with cardiac syndrome X.
    Büyükkaya E; Karakaş MF; Kurt M; Motor S; Akçay AB; Büyükkaya S; Karakaş E; Sen N
    Turk Kardiyol Dern Ars; 2013 Jun; 41(4):290-5. PubMed ID: 23760115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noninvasive evaluation of flow reserve in the left anterior descending coronary artery in patients with cardiac syndrome X.
    Galiuto L; Sestito A; Barchetta S; Sgueglia GA; Infusino F; La Rosa C; Lanza G; Crea F
    Am J Cardiol; 2007 May; 99(10):1378-83. PubMed ID: 17493464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ischemia with normal coronary arteries: a puzzle and an opportunity.
    Tritto I; Conti MG; Ambrosio G
    J Cardiovasc Med (Hagerstown); 2011 May; 12(5):309-10. PubMed ID: 21451332
    [No Abstract]   [Full Text] [Related]  

  • 13. Chronic inflammation and increased arterial stiffness in patients with cardiac syndrome X.
    Arroyo-Espliguero R; Mollichelli N; Avanzas P; Zouridakis E; Newey VR; Nassiri DK; Kaski JC
    Eur Heart J; 2003 Nov; 24(22):2006-11. PubMed ID: 14613736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum levels of C-reactive protein and uric acid in patients with cardiac syndrome X.
    Eroglu S; Elif Sade L; Yildirir A; Demir O; Bozbas H; Muderrisoglu H
    Acta Cardiol; 2009 Apr; 64(2):207-11. PubMed ID: 19476113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dietary Patterns Seem to Influence the Development of Perfusion Changes in Cardiac Syndrome X Patients.
    Szot W; Zając J; Kostkiewicz M; Kolarzyk E
    Adv Clin Exp Med; 2015; 24(3):453-62. PubMed ID: 26467134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired coronary microvascular and left ventricular diastolic function in patients with inflammatory bowel disease.
    Caliskan Z; Gokturk HS; Caliskan M; Gullu H; Ciftci O; Ozgur GT; Guven A; Selcuk H
    Microvasc Res; 2015 Jan; 97():25-30. PubMed ID: 25128749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic inflammation is related to coronary microvascular dysfunction in obese patients without obstructive coronary disease.
    Tona F; Serra R; Di Ascenzo L; Osto E; Scarda A; Fabris R; Montisci R; Famoso G; Tellatin S; Foletto M; Giovagnoni A; Iliceto S; Vettor R
    Nutr Metab Cardiovasc Dis; 2014 Apr; 24(4):447-53. PubMed ID: 24548662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Inflammation and Endothelial Dysfunction with Coronary Microvascular Resistance in Patients with Cardiac Syndrome X.
    Long M; Huang Z; Zhuang X; Huang Z; Guo Y; Liao X; Luo C
    Arq Bras Cardiol; 2017 Nov; 109(5):397-403. PubMed ID: 29069202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum concentrations of galectin-3 in patients with cardiac syndrome X.
    Bozcali E; Polat V; Aciksari G; Opan S; Bayrak IH; Paker N; Karakaya O
    Atherosclerosis; 2014 Nov; 237(1):259-63. PubMed ID: 25282685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic inflammation and coronary microvascular dysfunction in patients without risk factors for coronary artery disease.
    Recio-Mayoral A; Mason JC; Kaski JC; Rubens MB; Harari OA; Camici PG
    Eur Heart J; 2009 Aug; 30(15):1837-43. PubMed ID: 19502228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.